Stoichiometric-dependent physical stability of atorvastatin-lisinopril co-amorphous in stress testing

被引:2
作者
Shu, Yecheng [1 ]
Jia, Jirun [2 ]
Zhao, Peixu [1 ]
Bao, Rui [1 ]
Li, Wen [1 ]
Yang, Li [1 ,2 ]
Tang, Xing [2 ]
He, Zhonggui [1 ]
Fu, Qiang [1 ,3 ]
机构
[1] Shenyang Pharmaceut Univ, Wuya Coll Innovat, 103 Wenhua Rd, Shenyang 110016, Peoples R China
[2] Shenyang Pharmaceut Univ, Sch Pharm, 103 Wenhua Rd, Shenyang 110016, Peoples R China
[3] Minist Educ, Joint Int Res Lab Intelligent Drug Delivery Syst, Shenyang 110016, Peoples R China
关键词
Atorvastatin; Lisinopril; Co-amorphous; Physical stability; SOLID DISPERSION; GLASS-TRANSITION; DISSOLUTION RATE; INDOMETHACIN; PHARMACOKINETICS; CRYSTALLIZATION; SOLUBILITY; STRATEGIES; INHIBITORS; MIXTURES;
D O I
10.1016/j.jiec.2024.04.046
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Co-amorphous (CAM) is an effective pharmaceutical strategy to improve the aqueous solubility of poorly watersoluble drugs, however, the physical stability problem of converting into their crystalline counterparts under high temperature and high humidity conditions significantly limits their development. Stress testing can rapidly evaluate the physical stability, distinguish the quality differences, and recommend storage conditions. This study aims to further understand the physical stability of the atorvastatin-lisinopril CAMs with various stoichiometric ratios by stress testings, and clarify the deep mechanism at the molecular level by systemic characterization. CAMs were prepared by a cryo-milling method. Molecular modeling and molecular dynamics were used to predict potential intermolecular forces of CAMs. Then, they were stored under stress conditions, and the collected samples were subjected to PLM, DSC, PXRD, and in vitro dissolution tests. Raman and FT-IR spectroscopy were used to identify the intermolecular forces. The results showed that the physical stability of CAMs was stoichiometric-dependent. Regardless of the conditions tested, CAMs exhibited excellent physical stability at stoichiometric ratios of 2:1 and 1:1 because of the strong intermolecular forces. This study sheds light on the stoichiometric-dependent physical stability of the CAM strategy in stress testing, provides a mechanism clarification at the molecule level, and offers useful information on CAM storage.
引用
收藏
页码:175 / 184
页数:10
相关论文
共 31 条
[21]   Co-amorphous solid dispersion systems of lacidipine-spironolactone with improved dissolution rate and enhanced physical stability [J].
Wang, Zhaomeng ;
Sun, Mengchi ;
Liu, Tian ;
Gao, Zisen ;
Ye, Qing ;
Tan, Xiao ;
Hou, Yanxian ;
Sun, Jin ;
Wang, Dun ;
He, Zhonggui .
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 14 (01) :95-103
[22]   Co-Amorphous Formation of Simvastatin-Ezetimibe: Enhanced Physical Stability, Bioavailability and Cholesterol-Lowering Effects in LDLr-/-Mice [J].
Bahetibieke, Shamuha ;
Moinuddin, Sakib M. ;
Baiyisaiti, Asiya ;
Liu, Xiaoang ;
Zhang, Jie ;
Liu, Guomin ;
Shi, Qin ;
Peng, Ankang ;
Tao, Jun ;
Di, Chang ;
Cai, Ting ;
Qi, Rong .
PHARMACEUTICS, 2022, 14 (06)
[23]   Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies [J].
Liu, Jingwen ;
Grohganz, Holger ;
Lobmann, Korbinian ;
Rades, Thomas ;
Hempel, Nele-Johanna .
PHARMACEUTICS, 2021, 13 (03)
[24]   Solubility and Physical Stability Enhancement of Loratadine by Preparation of Co-Amorphous Solid Dispersion with Chlorpheniramine and Polyvinylpyrrolidone [J].
Suknuntha, Krit ;
Khumpirapang, Nattakanwadee ;
Tantishaiyakul, Vimon ;
Okonogi, Siriporn .
PHARMACEUTICS, 2023, 15 (11)
[25]   Co-amorphous Systems of Sinomenine with Platensimycin or Sulfasalazine: Physical Stability and Excipient-Adjusted Release Behavior [J].
Chen, Xin ;
Li, Duanxiu ;
Zhang, Hailu ;
Duan, Yanwen ;
Huang, Yong .
MOLECULAR PHARMACEUTICS, 2022, 19 (11) :4370-4381
[26]   Preparation of Amorphous Probucol with Fluvastatin Sodium Salt and Stability Comparison Studies of Co-amorphous Probucol with Fluvastatin Sodium Salt and Atorvastatin Calcium Trihydrate Salt [J].
Oyama, Shinji ;
Ogawa, Noriko ;
Yasunaga, Toshiya ;
Yamamoto, Hiromitsu .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2024, 72 (12) :1073-1083
[27]   Novel drug-drug co-amorphous systems of olaparib with nonsteroidal anti-inflammatory drugs with improved solubility, physical stability, antitumor activity and pharmacokinetics [J].
Luo, Zheng-Kang ;
Qin, Hui-Min ;
Han, Jin-Meng ;
Zhu, Jin ;
Zeng, Yu-Yu ;
Fan, Chang-Ping ;
Liu, Shu-Xian ;
Hao, Chao ;
Zhang, Jian ;
Zhuang, Tao .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 101
[28]   Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: Improved dissolution behavior and physical stability without evidence of intermolecular interactions [J].
Dengale, Swapnil J. ;
Ranjan, Om Prakash ;
Hussen, Syed Sajjad ;
Krishna, B. S. M. ;
Musmade, Prashant B. ;
Shenoy, G. Gautham ;
Bhat, Krishnamurthy .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 62 :57-64
[29]   Effect of molar ratios on formation, dissolution and physical stability of co-amorphous naringenin-meglumine by integrating theoretical-modeling-experimental techniques [J].
Han, Jiawei ;
Sun, Wen ;
Chen, Jiaxin ;
Yue, Zhimin ;
Fang, Weitao ;
Liu, Xiaoqian ;
Wang, Jue ;
Wu, Gaorong .
CRYSTENGCOMM, 2025, 27 (14) :2124-2135
[30]   Specific intermolecular interaction with sodium glycocholate generates the co-amorphous system showing higher physical stability and aqueous solubility of Y5 receptor antagonist of neuropeptide Y, a brick dust molecule [J].
Aikawa, Shohei ;
Tanaka, Hironori ;
Ueda, Hiroshi ;
Maruyama, Masato ;
Higaki, Kazutaka .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2024, 202